SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ:QDEL), a leader in point-of-care (POC) rapid diagnostic tests, today announced recent initiatives to educate and inform the healthcare community regarding methodologies and procedures for use of the Company’s QuickVue® Influenza A+B POC Test in advance of the coming flu season. QuickVue® is the #1 selling brand for rapid influenza tests in the professional market in the United States.
